Literature DB >> 8441666

Isolation of a cDNA encoding the adenovirus E1A enhancer binding protein: a new human member of the ets oncogene family.

F Higashino1, K Yoshida, Y Fujinaga, K Kamio, K Fujinaga.   

Abstract

The cDNA encoding adenovirus E1A enhancer-binding protein E1A-F was isolated by screening a HeLa cell lambda gt11 expression library for E1A-F site-specific DNA binding. One cDNA clone produced recombinant E1A-F protein with the same DNA binding specificity as that endogenous to HeLa cells. Sequence analysis of the cDNA showed homology with the ETS-domain, a region required for sequence-specific DNA binding and common to all ets oncogene members. Analysis of the longest cDNA revealed about a 94% identity in amino acids between human E1A-F and mouse PEA3 (polyomavirus enhancer activator 3), a recently characterized ets oncogene member. E1A-F was encoded by a 2.5kb mRNA in HeLa cells, which was found to increase during the early period of adenovirus infection. In contrast, ets-2 mRNA was significantly reduced in infected HeLa cells. The results indicate that E1A enhancer binding protein E1A-F is a member of the ets oncogene family and is probably a human homologue of mouse PEA3.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441666      PMCID: PMC309151          DOI: 10.1093/nar/21.3.547

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

Review 1.  Nuclear targets for transcription regulation by oncogenes.

Authors:  A Gutman; B Wasylyk
Journal:  Trends Genet       Date:  1991-02       Impact factor: 11.639

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Independently evolving chicken histone H2B genes: identification of a ubiquitous H2B-specific 5' element.

Authors:  R P Harvey; A J Robins; J R Wells
Journal:  Nucleic Acids Res       Date:  1982-12-11       Impact factor: 16.971

4.  A putative second cell-derived oncogene of the avian leukaemia retrovirus E26.

Authors:  D Leprince; A Gegonne; J Coll; C de Taisne; A Schneeberger; C Lagrou; D Stehelin
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

5.  Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus.

Authors:  L A Laimins; P Gruss; R Pozzatti; G Khoury
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

6.  The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element.

Authors:  P Hearing; T Shenk
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

View more
  15 in total

Review 1.  Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.

Authors:  Natasza A Kurpios; Nancy A Sabolic; Trevor G Shepherd; Gina M Fidalgo; John A Hassell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

2.  The ets-related mouse Pea3 gene maps to distal chromosome 11.

Authors:  K Noben-Trauth; J K Naggert; P M Nishina
Journal:  Mamm Genome       Date:  1996-07       Impact factor: 2.957

3.  Analysis of the ERK-stimulated ETS transcription factor ER81.

Authors:  R Janknecht
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 4.  ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta       Date:  2012-03-08

5.  Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities.

Authors:  K Hida; M Shindoh; M Yasuda; M Hanzawa; K Funaoka; T Kohgo; A Amemiya; Y Totsuka; K Yoshida; K Fujinaga
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

6.  Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines.

Authors:  M Shindoh; F Higashino; M Kaya; M Yasuda; K Funaoka; M Hanzawa; K Hida; T Kohgo; A Amemiya; K Yoshida; K Fujinaga
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 7.  Role of Ets transcription factors in mammary gland development and oncogenesis.

Authors:  T Shepherd; J A Hassell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

8.  Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300.

Authors:  S Papoutsopoulou; R Janknecht
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

9.  The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.

Authors:  Ben Davidson; Iris Goldberg; Liora Tell; Sophya Vigdorchik; Mark Baekelandt; Aasmund Berner; Gunnar B Kristensen; Reuven Reich; Juri Kopolovic
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

10.  Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.

Authors:  Rebecca Baker; Claire V Kent; Rachel A Silbermann; John A Hassell; Lawrence J T Young; Louise R Howe
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.